Masimo (MASI) Net Income towards Common Stockholders (2009 - 2026)

Masimo's (MASI) quarterly Net Income towards Common Stockholders came in at $800000.0 in Q2 2026, up 100.37% year-on-year from $399267.1 in Q2 2025, and down 87.5% quarter-over-quarter from $6.4 million in Q1 2026.

Masimo (MASI) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Masimo's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $800000.0 for Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 100.37% year-over-year to $800000.0 in Q2 2026; TTM through Apr 2026 was -$140.5 million, a 73.28% increase from a year earlier, with the FY2026 full-year figure at -$359.2 million, down 11.87% from the prior year.
  • Net Income towards Common Stockholders eased to $800000.0 in Q2 2026 per MASI's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $60.1 million in Q4 2023 and bottomed at -$284.6 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is $8.5 million (2023), against an average of -$20.5 million.
  • Biggest YoY gain for Net Income towards Common Stockholders was 172.73% in 2025; the steepest drop was 1550.76% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at $40.9 million in 2022, then soared by 46.94% to $60.1 million in 2023, then sank by 573.54% to -$284.6 million in 2024, then soared by 45.85% to -$154.1 million in 2025, then soared by 100.52% to $800000.0 in 2026.
  • Per Business Quant, the three latest MASI Net Income towards Common Stockholders figures stand at $800000.0 (Q2 2026), $6.4 million (Q1 2026), and -$154.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn 800,000.00

Historic Data

Download Data
DateValue
Apr 4, 2026 800,000.00
Jan 3, 2026 6.40 Mn
Sep 27, 2025 -154.10 Mn
Jun 28, 2025 6.40 Mn
Mar 29, 2025 -217.90 Mn
Dec 28, 2024 -284.60 Mn
Sep 28, 2024 -14.50 Mn
Jun 29, 2024 -8.80 Mn
Mar 30, 2024 -13.20 Mn
Dec 30, 2023 60.10 Mn
Sep 30, 2023 10.60 Mn
Jul 1, 2023 15.70 Mn
Apr 1, 2023 21.30 Mn
Dec 31, 2022 40.90 Mn
Oct 1, 2022 37.90 Mn
Jul 2, 2022 18.10 Mn
Apr 2, 2022 46.60 Mn
Jan 1, 2022 59.97 Mn
Oct 2, 2021 57.80 Mn
Jul 3, 2021 50.20 Mn